Child health
Investigations and monitoring
An 11-year-old boy with asthma is reassessed in an Adelaide emergency department 4 hours after presenting with a viral-triggered exacerbation. He initially spoke in short phrases with recession and has received frequent then hourly salbutamol by spacer, ipratropium in the first hour and oral prednisolone. He is now speaking in full sentences, with equal air entry bilaterally, faint end-expiratory wheeze and no recession. RR is 34/min, HR 156/min, BP 110/66 mmHg, SpO2 96% on room air and temperature 37.0 °C. He has a new fine tremor, is well perfused and has no chest pain or productive cough. His next hourly salbutamol dose is due, and the team is unsure whether his tachypnoea reflects ongoing bronchospasm. Which investigation is most appropriate before deciding on that dose?
Answer this question